We are committed to rigorous science and innovative drug development, and we are excited to share our ongoing progress.
Showing 2 out of 2
Clermont A, Murugesan N, Zhou Q, Kita T, Robson PA, Rushbrooke LJ, Evans DM, Aiello LP, and Feener EP.
Invest Ophthalmol Vis Sci. 2016; 57:2390-9.
PMID:27138737
Phipps JA and Feener EP.
Kidney Int., 2008;73(10):1114-9.
PMID:18272958